Dina Hany

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 11

Top Topics

Estrogen Receptor

High Throughput

Breast Cancer Cells

Top Venues

Cellular and molecular life sciences : CMLS

Science advances

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Dina Hany, Vasiliki Vafeiadou, Didier Picard
CRISPR-Cas9 screen reveals a role of purine synthesis for estrogen receptor α activity and tamoxifen resistance of breast cancer cells. Science advances 9 (19) (2023)
Dina Hany, Marloes Zoetemelk, Kaushik Bhattacharya, Patrycja Nowak-Sliwinska, Didier Picard
Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer. Cellular and molecular life sciences : CMLS 80 (3) (2023)
Dina Hany, Vasiliki Vafeiadou, Didier Picard
CRISPR-Cas9 screen reveals a role of purine synthesis for estrogen receptor α activity and tamoxifen resistance of breast cancer cells. Science advances 9 (19) (2023)
Dina Hany, Marloes Zoetemelk, Kaushik Bhattacharya, Patrycja Nowak-Sliwinska, Didier Picard
Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer. Cellular and molecular life sciences : CMLS 80 (3) (2023)
Dina Hany, Vasiliki Vafeiadou, Didier Picard
CRISPR-Cas9 screen reveals a role of purine synthesis for estrogen receptor α activity and tamoxifen resistance of breast cancer cells. Science advances 9 (19) (2023)
Dina Hany, Marloes Zoetemelk, Kaushik Bhattacharya, Patrycja Nowak-Sliwinska, Didier Picard
Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer. Cellular and molecular life sciences : CMLS 80 (3) (2023)
Dina Hany, Vasiliki Vafeiadou, Didier Picard
CRISPR-Cas9 screen reveals a role of purine synthesis for estrogen receptor α activity and tamoxifen resistance of breast cancer cells. Science advances 9 (19) (2023)
Dina Hany, Marloes Zoetemelk, Kaushik Bhattacharya, Patrycja Nowak-Sliwinska, Didier Picard
Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer. Cellular and molecular life sciences : CMLS 80 (3) (2023)
Dina Hany, Marloes Zoetemelk, Kaushik Bhattacharya, Patrycja Nowak-Sliwinska, Didier Picard
Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer. Cellular and molecular life sciences : CMLS 80 (3) (2023)
Kaushik Bhattacharya, Samarpan Maiti, Szabolcs Zahoran, Lorenz Weidenauer, Dina Hany, Diana Wider, Lilia Bernasconi, Manfredo Quadroni, Martine A Collart, Didier Picard
Translational reprogramming in response to accumulating stressors ensures critical threshold levels of Hsp90 for mammalian life. Nature communications 13 (1) (2022)
Vasiliki Vafeiadou, Dina Hany, Didier Picard
Hyperactivation of MAPK Induces Tamoxifen Resistance in SPRED2-Deficient ERα-Positive Breast Cancer. Cancers 14 (4) (2022)